Newsletter
The Hahnemann Monument: Its History and Its Architecture
The following is taken from a presentation made in April 2010 at the Samuel Hahnemann Monument in Washington D.C. by Sandra M. Chase, MD, DHt, then president of the American…
Read MoreGet Ready: FDA Revised the National Drug Code and Drug Label Barcode
In March 2026, the U.S. Food and Drug Administration (FDA) finalized its rule to standardize the format of the National Drug Code (NDC). Under this rule, FDA will move from…
Read MoreThe Development of Homeopathy and Homeopathic Pharmacy in the United States
Introduction Homeopathy emerged in the late eighteenth century as a systematic reform movement within European medicine and, within a generation, established a substantial institutional presence in the United States. As…
Read MoreSamuel Hahnemann: A Very Brief Biography
By Jay Yasgur, R.Ph. (ret.), M.Sc. Hahnemann (1755–1843) was born in Meissen, Germany, a locale famous for the production of fine porcelain — his father was a skilled porcelain painter. Hahnemann studied medicine in Vienna and Leipzig…
Read MorePreserving the Story of Homeopathy
By Mark Land, M.S., RAC-US, AAHP President While preparing for this issue, I thought about rigor in historical reporting. Many of us are aware of the risks associated with biased reporting. Historians have some basic…
Read MoreNew FDA Draft Guidance on Responding to 483 Observations; What Drug Manufacturers Need to Know Now
By Eric L. Foxman, Pharm. (Ret.) In March 2026, FDA released a significant draft guidance which presents consolidated and formalized expectations for drug manufacturers responses to FDA Form 483 Inspection…
Read MoreBranding Part II: How to Create a Motivating, Sustainable Brand Positioning / Strategy
By Cynthia Batterman This article originally appeared in the October 2011 hardcopy-only edition of the AAHP Network News. Building upon a previous article on the importance of a brand positioning…
Read MoreBranding Part I: A Positioning Statement Is Mission Critical to Your Business
By Cynthia Batterman This article originally appeared in the August 2011 hardcopy-only edition of the AAHP Network News. One of the most important strategic projects that any company can pursue is the development of its…
Read MoreUsing AI-Powered Sentiment Analysis to Strengthen Marketing and Differentiation in Homeopathic Products
By Brenda van Goethem, Director of Regulatory Compliance and Change Management at Nature’s Way Brands, LLC (Schwabe North America) and AAHP Board of Director Artificial intelligence (AI) is rapidly reshaping…
Read MoreMarketing of Homeopathic Drug Products: OTC vs. Rx-only
By Eric L. Foxman, Pharm. (Ret.) On a single day in mid-November, FDA issued five warning letters* to a like number of distributors / manufacturers of homeopathic drug products. The cause? The firms were cited because “the…
Read More